Universal face masking during anti-VEGF injections reduces endophthalmitis incidence
Sunir J. Garg, MD, speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.
Modern Retina's Sheryl Stevenson speaks with Sunir J. Garg, MD, co-director of retina research at the Wills Eye Hospital in Baltimore, Maryland, on the highlights of his presentation at the 2021 annual American Academy of Ophthalmology (AAO) meeting regarding the impact of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injections.
The American Academy of Ophthalmology (AAO) annual meeting was held November 12 to 15 at the Ernest N. Morial Convention Center in New Orleans, Louisiana. The event included Subspecialty Days and a virtual component for remote participation.
Related Content: Additional AAO Content | Ophthalmology | Conference Coverage
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
